Masonite price target lowered to $82 from $95 at Wedbush » 07:5903/3003/30/20
Wedbush analyst Jay…
Wedbush analyst Jay McCanless lowered the firm's price target on Masonite to $82 from $95 and keeps an Outperform rating on the shares. The analyst resets his estimates to reflect a 2-week work stoppage in the company's U.K. operations, a slower growth rate for Masonite's North American Residential segment, and a higher SG&A to sales assumption in anticipation of COVID-19-related costs. McCanless also notes that the company announced the fiscal year 2020 guidance is under review.
Masonite removed from Best Ideas List at Wedbush » 07:5703/3003/30/20
Wedbusha removed Masonite…
Story temporarily locked.
Hi-Crush Inc. to hold 2020 Annual Stockholder Meeting as virtual event » 16:2003/2703/27/20
Hi-Crush announced that…
Hi-Crush announced that in consideration of ongoing concerns surrounding the COVID-19 pandemic, and uncertainty with respect to the duration of certain travel and gathering restrictions, the board of directors of the company has elected to hold the company's 2020 Annual Meeting of Stockholders on Friday, May 22, in a virtual meeting format only. The Board had previously announced an expectation to hold the 2020 Annual Meeting on Wednesday, May 20, but has determined to reschedule the 2020 Annual Meeting to Friday, May 22, in order to accommodate the virtual meeting format. Instructions on how to participate in the virtual meeting will be specified in the company's proxy statement for the 2020 Annual Meeting.
Hologic upgraded to Equal Weight from Underweight at Morgan Stanley » 08:5303/2703/27/20
Morgan Stanley analyst…
Morgan Stanley analyst David Lewis upgraded Hologic to Equal Weight from Underweight with a $40 price target. While its elective mix and modest capital exposure risks are "clear," he thinks these risks appear to be price in at current valuation. Also, COVID-19 diagnostic testing could prove to be a modest offset over the intermediate-term, Lewis tells investors.
|Over a week ago|
Avaya, Telarus sign master agent agreement » 08:1203/1903/19/20
Avaya announced that…
Avaya announced that Telarus has been named as a master agent for its Avaya Cloud Office by RingCentral offering. Avaya Cloud Office is a collaboration solution providing communications, file sharing, and collaboration capabilities across unified voice, video, messaging, digital customer engagement and meetings. Telarus will provide this new Avaya UCaaS offer to its extensive network of over 4,000 technology brokers.
Fortress Transportation trading resumes 09:4403/1803/18/20
Fortress Transportation trading halted, volatility trading pause 09:3903/1803/18/20
B. Riley FBR says be 'highly selective' in Oilfield Services, downgrades three » 08:4103/1703/17/20
PUMP, RNGR, USAC, WTTR, LBRT, SOI, AROC
B. Riley FBR analyst…
B. Riley FBR analyst Thomas Curran downgraded ProPetro Holding (PUMP), Ranger Energy (RNGR) and USA Compression (USAC) to Neutral from Buy. Despite the "historic meltdown" that has occurred in Oilfield Services stocks, investors should "remain highly selective in attempted bottom fishing," Curran tells investors in a research note. The analyst now forecasts onshore exploration and production capital expenditure declines by 41% and narrowed his top completion and production picks to just four names: Select Energy Services (WTTR), Liberty Oilfield Services (LBRT), Solaris Oilfield (SOI) and Archrock (AROC).
USA Compression downgraded to Neutral from Buy at B. Riley FBR » 04:4703/1703/17/20
B. Riley FBR analyst…
B. Riley FBR analyst Thomas Curran downgraded USA Compression Partners to Neutral from Buy with a price target of $14, down from $20.
Hologic COVID-19 test gets FDA emergency use authorization » 19:5603/1603/16/20
Hologic announced today…
Hologic announced today that the FDA has granted Emergency Use Authorization for the Company's new Panther Fusion SARS-CoV-2 assay, a molecular diagnostic test that detects SARS-CoV-2, the virus that causes COVID-19 disease. Hospital, public health and reference laboratories can perform the test on Hologic's Panther Fusion system, a fully automated, high-throughput molecular diagnostic platform that is widely used across the United States. Each Panther Fusion system can provide results in less than three hours and process up to 1,150 coronavirus tests in a 24-hour period. Using the Panther Fusion system, healthcare providers can test for SARS-CoV-2 from the same patient sample and collection vial that they currently use to diagnose other common respiratory viruses whose symptoms overlap with COVID-19, boosting efficiency and increasing clinical insight. With a small physical footprint and a broad menu that includes 16 FDA-cleared tests for various infectious diseases, the Panther Fusion system is already widely used in low-, medium- and high-throughput laboratories.